Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neuroblastoma × Drug Therapy × Clear all

Phase

Status

Completed 3 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Anus Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Select Advanced Solid Tumors 1 SCLC 1 Radiation Therapy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pain 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1

Interventions

Cyclophosphamide 11 Magnetic Resonance Spectroscopy 8 dinutuximab 6 Topotecan 6 Temozolomide 6 Irinotecan 6 Biopsy 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 sargramostim 3 Isotretinoin 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Etoposide 3 Colony-Stimulating Factors 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 naxitamab 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 fludarabine 2 erdafitinib 2 ensartinib 2 Nivolumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05421897 2026-01-29

RAPID

Children's Hospital Los Angeles

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡